enVVeno Medical Participates in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
-
Kyrgios targets 'miracle' Australian Open return after knee improves
-
'AI president': Trump deepfakes glorify himself, trash rivals
-
Belgium probes drone sightings after flights halted overnight
-
Five things to know about 'forest COP' host city Belem
-
World leaders to rally climate fight ahead of Amazon summit
-
Engine fell off US cargo plane before deadly crash: officials
-
Mexican leader calls for tougher sexual harassment laws after attack
-
Meghan Markle set for big screen return: reports
-
Japan deploys troops after wave of deadly bear attacks
-
FIFA announce new peace prize to be awarded at World Cup draw in Washington
-
Australia's Cummins hints at return for second Ashes Test
-
Boeing settles with one plaintiff in 737 MAX crash trial
-
Man City win as Inter stay perfect, Barca held in Champions League
-
French superstar DJ Snake wants new album to 'build bridges'
-
Barca rescue draw at Club Brugge in six-goal thriller
-
Foden hits top form as Man City thrash Dortmund
-
NBA officials brief Congress committee over gambling probe
-
Inter beat Kairat Almaty to maintain Champions League perfection
-
Newcastle sink Bilbao to extend Champions League winning run
-
Wall Street stocks rebound after positive jobs data
-
LPGA, European tour partner with Saudis for new Vegas event
-
Eyes turn to space to feed power-hungry data centers
-
Jazz lose Kessler for season with shoulder injury
-
League scoring leader Messi among MLS Best XI squad
-
MLS bans Suarez for Miami's winner-take-all playoff match
-
McIlroy appreciates PGA of America apology for Ryder Cup abuse
-
Garnacho equaliser saves Chelsea in Qarabag draw
-
Promotions lift McDonald's sales in tricky consumer market
-
Five things to know about New York's new mayor
-
Anisimova beats Swiatek to reach WTA Finals last four
-
US Supreme Court appears skeptical of Trump tariff legality
-
AC Milan post third straight annual profit on day of San Siro purchase
-
Angelina Jolie visits Ukrainian frontline city, media reports say
-
UN says forests should form key plank of COP30
-
Star designer Rousteing quits fashion group Balmain
-
Mexico's Sheinbaum steps up cartel fight after murder of anti-narco mayor
-
Attack on funeral in Sudan's Kordofan region kills 40: UN
-
Key PSG trio set for spell on sidelines
-
Democrats punch back in US elections - and see hope for 2026
-
BMW reports rising profitability, shares jump
-
US Supreme Court debates legality of Trump's tariffs
-
Bolivia Supreme Court orders release of jailed ex-president Jeanine Anez
-
Wall Street stocks rise after positive jobs data
-
'Hostage diplomacy': longstanding Iran tactic presenting dilemma for West
-
Rybakina stays perfect at WTA Finals with win over alternate Alexandrova
-
Le Garrec welcomes Dupont help in training for Springboks showdown
-
Brussels wants high-speed rail linking EU capitals by 2040
-
Swiss business chiefs met Trump on tariffs: Bern
-
At least 9 dead after cargo plane crashes near Louisville airport
-
France moves to suspend Shein website as first store opens in Paris
NYSE - LSE
enVVeno Medical Participates in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
- Video webcast now available on-demand
IRVINE, CA / ACCESS Newswire / July 22, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that Rob Berman, CEO of enVVeno, participated in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference.
As part of the segment, Mr. Berman dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company's products in development.
The on-demand video webcast is now available on virtualinvestorco.com as well as the Events page of the enVVeno website, envveno.com.
About enVVeno Medical Corporation
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company's lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insuffihttps://virtualinvestorco.com/summer-spotlight/cy (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the VenoValve U.S. pivotal study and the Company is currently performing the final testing necessary to seek approval for the pivotal trial for enVVe.
INVESTOR CONTACT:
Jenene Thomas, JTC Team, LLC
[email protected]
(908) 824-0775
MEDIA CONTACT:
Glenn Silver, FINN Partners
[email protected]
(973) 818-8198
SOURCE: enVVeno Medical Corporation
View the original press release on ACCESS Newswire
M.Thompson--AMWN
